Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists to Treat Addiction - Dr Stephanie Weiss

Objectives:
1. Explain the pharmacology and toxicology of GLP-1 receptor agonists
2. Evaluate the preclinical evidence in favor of repurposing GLP-1 receptor agonists as possible addiction pharmacotherapies
3. Assess some of the ongoing clinical trials studying the safety and efficacy of GLP-1 receptor agonists for addiction
4. Identify common and rare but concerning possible adverse effects of manufactured and compounded semaglutide formulations